Literature DB >> 3452852

Suppression of bony growth of the orbit after radiotherapy for retinoblastoma.

S Egawa1, I Tsukiyama, Y Akine, Y Kajiura, T Ogino.   

Abstract

Suppression of the growth of orbit and skull in 13 retinoblastoma patients treated by radiotherapy was investigated. The age of patients at the time of treatment ranged from 1 month to 6 years and 11 months. They were examined after three to 18 years. Suppression of the growth in involved areas and other parts of the skull within the beam of radiation were estimated by inspection, X-ray findings, and X-CT examinations. The involved orbit received more than 32 Gy, and the suppression of bone growth was prominent. At the opposite temporal bone, suppression of growth was prominent in eight cases out of 11, in these cases, the radiation dose was at least 14 Gy. Two cases, in whom the radiation dose was less than 12.6 Gy, have not shown any suppression of bony growth. Results were also obtained for a nominal single dose (ret). In all cases of more than 1,000 ret, suppression was prominent, but at less than 1,000 ret, four out of nine cases, and at less than 600 ret, two out of four cases showed suppression of bony growth. If the safety dose to avoid the suppression of bony growth is 400 ret, this is equivalent to three times the radiation dose of 200 cGy. In conclusion, the suppression of bony growth of the orbit and temporal area of the skull of young patients is caused by very small doses of radiation.

Entities:  

Mesh:

Year:  1987        PMID: 3452852

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  4 in total

1.  The hourglass facial deformity as a consequence of orbital irradiation for bilateral retinoblastoma.

Authors:  N C Yue; M L Benson
Journal:  Pediatr Radiol       Date:  1996

2.  Quantification of lacrimal function after D-shaped field irradiation for retinoblastoma.

Authors:  S M Imhof; P Hofman; K E Tan
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

3.  Bony orbital morphology in neurofibromatosis type 1 (NF1).

Authors:  S C Kaste; E K Pivnick
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

4.  Long-term treatment effects in patients with bilateral retinoblastoma: ocular and mid-facial findings.

Authors:  E P Messmer; H Fritze; C Mohr; T Heinrich; W Sauerwein; W Havers; B Horsthemke; W Höpping
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.